☆ 4.8 Article

Humoral and cellular immune response and the safety of third SARS-CoV-2 mRNA vaccine with longer interval after the second vaccination in kidney transplant recipients

FRONTIERS IN IMMUNOLOGY (2022)

Related references

Note: Only part of the references are listed.

Letter Medicine, General & Internal

Antibody Response to a Fourth Messenger RNA COVID-19 Vaccine Dose in Kidney Transplant Recipients: A Case Series

Sophie Caillard et al.

ANNALS OF INTERNAL MEDICINE (2022)

Add to Collection

Article Urology & Nephrology

Impact of tozinameran (BNT162b2) mRNA vaccine on kidney transplant and chronic dialysis patients: 3-5 months follow-up

Iddo Z. Ben-Dov et al.

Summary: This study aimed to determine the humoral immunogenicity of tozinameran in patients requiring chronic renal replacement therapy and its impact on COVID-19 morbidity. The results showed that dialysis patients and kidney transplant recipients had reduced antibody response to the COVID-19 vaccine, and this reduced response was associated with higher infection rates.

JOURNAL OF NEPHROLOGY (2022)

Add to Collection

Article Urology & Nephrology

The Impact of Vaccination on Incidence and Outcomes of SARS-CoV-2 Infection in Patients with Kidney Failure in Scotland

Samira Bell et al.

Summary: The study in Scotland found that 93% of KRT-treated patients had received two doses of an approved COVID-19 vaccine, but the effectiveness of the vaccine against infection and hospitalization was only 33% and 38%, respectively. Fully vaccinated patients had higher mortality rates and additional strategies are urgently needed to reduce the risk of COVID-19 infection and complications in this population.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2022)

Add to Collection

Letter Surgery

Efficiency of a boost with a third dose of anti-SARS-CoV-2 messenger RNA-based vaccines in solid organ transplant recipients

Arnaud Del Bello et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2022)

Add to Collection

Letter Immunology

Effectiveness of COVID-19 Vaccines Against Hospitalization and Death With the SARS-CoV-2 Delta Variant in Solid Organ and Islet Transplant Recipients

Sarah V. Williams et al.

TRANSPLANTATION (2022)

Add to Collection

Letter Immunology

Antibody Response to a Fourth Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: An Update

Jonathan Mitchell et al.

TRANSPLANTATION (2022)

Add to Collection

Article Immunology

Breakthrough Infections Following mRNA SARS-CoV-2 Vaccination in Kidney Transplant Recipients

Auxiliadora Mazuecos et al.

Summary: The clinical effectiveness of COVID-19 vaccination in kidney transplant recipients is lower than in the general population. Despite receiving 2 doses of the mRNA vaccine, the severity of COVID-19 remains high in KT patients. KT patients vaccinated with mRNA-1273 vaccine show higher clinical effectiveness in breakthrough infections.

TRANSPLANTATION (2022)

Add to Collection

Letter Immunology

Real-world Impact of 2-dose SARS-CoV-2 Vaccination in Kidney Transplant Recipients

Caitriona M. McEvoy et al.

TRANSPLANTATION (2022)

Add to Collection

Article Urology & Nephrology

Immunogenicity and safety of two doses of SARS-CoV-2 mRNA vaccine in kidney transplant recipients with low-dose rituximab

Satoshi Takai et al.

Summary: This study evaluated the impact of low-dose rituximab treatment history on safety profiles and immune responses in kidney transplant recipients after receiving the COVID-19 mRNA vaccine. The results showed that rituximab did not significantly affect humoral or cellular responses, and did not result in severe systemic adverse events.

INTERNATIONAL JOURNAL OF UROLOGY (2022)

Add to Collection

Article Infectious Diseases

Global impact of the first year of COVID-19 vaccination: a mathematical modelling study

Oliver J. Watson et al.

Summary: A study quantified the global impact of the first year of COVID-19 vaccination programs, finding that the vaccination has substantially altered the course of the pandemic, saving tens of millions of lives globally. However, inadequate access to vaccines in low-income countries has limited the impact, reinforcing the need for global vaccine equity and coverage.

LANCET INFECTIOUS DISEASES (2022)

Add to Collection

Article Surgery

Immune Response to Third Dose BNT162b2 COVID-19 Vaccine Among Kidney Transplant Recipients-A Prospective Study

Dafna Yahav et al.

Summary: The immune response to two doses of SARS-CoV-2 mRNA vaccine is limited among kidney transplant recipients. This study aimed to evaluate the humoral and cellular response to a third dose of the BNT162b2 vaccine. The results showed that the third dose improved the immune response among kidney transplant recipients, although 30% of them remained seronegative. Temporary reduction of immunosuppression before vaccination was found to improve the antibody response.

TRANSPLANT INTERNATIONAL (2022)

Add to Collection

Article Infectious Diseases

Global impact of the first year of COVID-19 vaccination: a mathematical modelling study

Oliver J. Watson et al.

Summary: The study estimated that COVID-19 vaccination has prevented millions of deaths globally between December 8, 2020, and December 8, 2021. Achieving the vaccination coverage targets set by COVAX and WHO could have prevented even more deaths. However, limited access to vaccines in low-income countries has hindered the impact, highlighting the importance of global vaccine equity.

LANCET INFECTIOUS DISEASES (2022)

Add to Collection

Letter Urology & Nephrology

Antibody and T-cell response to a third dose of SARS-CoV-2 mRNA BNT162b2 vaccine in kidney transplant recipients

Dominique Bertrand et al.

KIDNEY INTERNATIONAL (2021)

Add to Collection

Editorial Material Urology & Nephrology

COVID-19 vaccination in kidney transplant recipients

Sophie Caillard et al.

Summary: Kidney transplant recipients, due to therapeutic immunosuppression, have impaired immune responses to the COVID-19 mRNA vaccine, necessitating a personalized intensified vaccination approach for better protection.

NATURE REVIEWS NEPHROLOGY (2021)

Add to Collection

Article Medicine, General & Internal

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

Merryn Voysey et al.

Summary: The AZD1222 vaccine has been approved for emergency use in the UK with an interval of 4-12 weeks between doses. Analysis shows that the vaccine is efficacious with two doses and provides immunoprotection after the first dose before the second dose is administered.

LANCET (2021)

Add to Collection

Article Surgery

Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belatacept

Nathalie Chavarot et al.

Summary: Poor responses to mRNA COVID-19 vaccine were observed in kidney transplant recipients treated with belatacept, especially in those without prior COVID-19 history. However, patients with a history of COVID-19 developed a strong antibody response with high titers after vaccination. Further strategies are needed to improve protection in this population.

AMERICAN JOURNAL OF TRANSPLANTATION (2021)

Add to Collection

Letter Medicine, General & Internal

Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series

William A. Werbel et al.

ANNALS OF INTERNAL MEDICINE (2021)

Add to Collection

Article Oncology

Alternative Evaluation of an ELISPOT Assay Using Cytokine Activity as a Novel Parameter

Chie Maeda et al.

Summary: The study concluded that cytokine activity, as a new parameter, did not show any advantages in evaluating T cell immune responses compared to the existing spot number parameter, based on data from previous clinical trials.

ANTICANCER RESEARCH (2021)

Add to Collection

Letter Medicine, General & Internal

Antibody Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Kidney Transplant Recipients With Minimal Serologic Response to 2 Doses

Ilies Benotmane et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Add to Collection

Letter Urology & Nephrology

A third injection of the BNT162b2 mRNA COVID-19 vaccine in kidney transplant recipients improves the humoral immune response

Christophe Masset et al.

KIDNEY INTERNATIONAL (2021)

Add to Collection

Letter Urology & Nephrology

Occurrence of severe COVID-19 in vaccinated transplant patients

Sophie Caillard et al.

KIDNEY INTERNATIONAL (2021)

Add to Collection

Letter Medicine, General & Internal

Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients

Nassim Kamar et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel

Yinon M. Bar-On et al.

Summary: After receiving a third dose of the BNT162b2 mRNA vaccine, Israeli residents aged 60 and above who had previously received two doses of the vaccine saw significantly lower rates of confirmed Covid-19 infection and severe illness compared to those who did not receive a booster shot, indicating the effectiveness of the booster dose in reducing infection and severe illness.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Letter Immunology

Cellular and Humoral Immune Responses After 3 Doses of BNT162b2 mRNA SARS-CoV-2 Vaccine in Kidney Transplant

Julian Stumpf et al.

TRANSPLANTATION (2021)

Add to Collection

Letter Immunology

Risk of Breakthrough SARS-CoV-2 Infections in Adult Transplant Recipients

Caroline X. Qin et al.

TRANSPLANTATION (2021)

Add to Collection

Editorial Material Immunology

Antibody Response to a Fourth Dose of a SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series

Jennifer L. Alejo et al.

TRANSPLANTATION (2021)

Add to Collection

Article Multidisciplinary Sciences

Modeling the effect of boost timing in murine irradiated sporozoite prime-boost vaccines

Cristina Fernandez-Arias et al.

PLOS ONE (2018)

Add to Collection

Article Medicine, General & Internal

A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA

K. Ewer et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Add to Collection

Article Biophysics

Investigation of the freely available easy-to-use software 'EZR' for medical statistics

Y. Kanda

BONE MARROW TRANSPLANTATION (2013)

Add to Collection

Article Immunology

Prime-Boost Interval Matters: A Randomized Phase 1 Study to Identify the Minimum Interval Necessary to Observe the H5 DNA Influenza Vaccine Priming Effect

Julie E. Ledgerwood et al.

JOURNAL OF INFECTIOUS DISEASES (2013)

Add to Collection

© Peeref 2019-2024. All rights reserved.